Purple Biotech reported cash from operations of -$2.50M and free cash flow of -$2.50M for the quarter ended Jun 2026, down 62.1% year over year. This cash flow statement covers 26 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2014 | Dec2014 | Sep2015 | Dec2015 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | 3.15M | 5.11M | -7.32M | -3.55M | -4.85M | -6.04M | -4.90M | -5.16M | -5.05M | -4.86M | -3.78M | -2.42M | -0.67M | -0.41M | -0.46M | -1.09M | -1.30M | -23.64M | -0.09M | -0.44M | ||||||
| Depreciation and Depletion | 0.06M | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.05M | 0.06M | 0.05M | 0.07M | 0.07M | ||||||
| Share-based Compensation | 0.39M | 0.30M | 0.31M | 0.56M | 0.71M | 0.84M | 0.75M | 0.49M | 0.45M | 0.18M | 0.27M | 0.22M | 0.13M | -0.03M | 0.09M | 0.06M | 0.20M | -0.04M | 0.09M | 0.07M | ||||||
| Cash from Discontinued Operations | -0.03M | -0.37M | ||||||||||||||||||||||||
| Cash from Operations | -2.91M | -3.54M | -5.20M | -3.70M | -3.62M | -4.21M | -6.06M | -5.22M | -3.66M | -4.98M | -5.08M | -3.98M | -3.29M | -2.01M | -1.98M | -1.54M | -1.07M | -1.07M | -3.12M | -2.50M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.06M | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.05M | 0.06M | 0.05M | 0.07M | 0.07M | ||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Account Payables | -0.14M | 1.20M | 2.73M | -2.82M | 1.62M | 1.64M | -1.50M | 0.87M | 1.04M | 0.18M | -0.67M | 0.18M | -1.14M | -0.45M | 0.13M | -0.95M | -0.02M | 1.29M | 0.30M | -2.04M | ||||||
| Change in Accured Expenses | -0.04M | -0.04M | -0.04M | -0.04M | -0.04M | -0.04M | -0.04M | -0.04M | -0.04M | -0.04M | -0.04M | -0.05M | -0.04M | -0.05M | -0.05M | -0.04M | -0.06M | -0.06M | -0.06M | -0.07M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital Expenditures | -0.01M | -0.01M | -0.01M | -0.01M | -0.00M | -0.00M | 0.00M | |||||||||||||||||||
| Change in Intangibles | -0.20M | 0.00M | ||||||||||||||||||||||||
| Acquisitions | -3.55M | |||||||||||||||||||||||||
| Change in Acquisitions & Divestments | 1.40M | 0.14M | 20.30M | -6.00M | 5.36M | 15.80M | 0.00M | 0.00M | -0.01M | -0.00M | 0.00M | -0.01M | -0.01M | 0.01M | 0.00M | -0.01M | ||||||||||
| Cash from Investing Activities | 1.57M | 5.06M | 17.72M | -5.98M | 0.18M | 8.00M | 12.60M | 0.20M | 1.01M | 0.07M | 0.31M | 0.09M | 0.07M | 0.04M | 0.26M | 0.11M | 0.37M | -0.10M | 0.04M | 0.00M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activities | -0.00M | 5.00M | -2.50M | 0.02M | 16.78M | 8.00M | ||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||
| Non-Current Debt | ||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | ||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | -0.06M | 0.48M | 0.16M | 0.29M | 0.57M | 0.09M | 0.26M | 0.37M | 0.57M | 4.25M | 0.27M | 0.43M | 2.13M | 3.94M | 0.10M | 0.37M | 5.57M | 0.30M | -0.06M | 2.12M | ||||||
| Exchange Rate Effect | -0.00M | -0.01M | -0.03M | -0.15M | -0.06M | 0.08M | 0.05M | -0.02M | -0.02M | 0.05M | -0.00M | -0.01M | 0.00M | -0.01M | 0.04M | -0.02M | -0.00M | -0.01M | 0.05M | |||||||
| Change in Cash | -1.42M | 1.78M | 12.68M | -9.38M | -2.88M | 3.87M | 6.80M | -4.66M | -2.08M | -0.66M | -4.50M | -3.46M | -1.09M | 1.96M | -1.62M | -1.07M | 4.87M | -0.87M | -3.14M | -0.38M | ||||||
| Beginning Cash Balance | 9.12M | 10.89M | 11.07M | 15.03M | 15.10M | 14.49M | 7.40M | 8.72M | ||||||||||||||||||
| Free Cash Flow | -2.90M | -3.54M | -5.19M | -3.69M | -3.62M | -4.21M | -6.06M | -5.22M | -3.66M | -4.98M | -5.08M | -3.98M | -3.29M | -2.01M | -1.98M | -1.54M | -1.07M | -1.07M | -3.12M | -2.50M | ||||||
| Net Cash Flow | -1.39M | 2.00M | 12.68M | -9.38M | -2.88M | 3.87M | 6.80M | -4.66M | -2.08M | -0.66M | -4.50M | -3.46M | -1.09M | 1.96M | -1.62M | -1.07M | 4.87M | -0.87M | -3.14M | -0.38M |
Pull Purple Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=PPBT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "PPBT", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=PPBT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();